Alpha 2.0
Login Register
» Authors » Mikako Goto

Mikako Goto

Explore the profile of Mikako Goto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 91
Followers 0
Related Specialties
Rheumatology
Gynecology & Obstetrics
Science
Top 10 Co-Authors
Atsuko Murashima
Naho Yakuwa
Kayoko Kaneko
Akimasa Yamatani
Ken Nakajima
Jumpei Saito
Kunihiko Takahashi
Ritsuko Yamane
Chinatsu Takai
Yoshiyuki Saito
Published In
Congenit Anom (Kyoto)
Mod Rheumatol
Rheumatology (Oxford)
Sci Rep
Int J Rheum Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol
Goto M, Saito S, Scheuerle A, Yasuda S, Houston N, Kumke T, et al.
Int J Rheum Dis . 2025 Jan; 28(1):e70048. PMID: 39812078
Aim: Uncontrolled chronic inflammatory diseases (CIDs) before, during, and after pregnancy, as well as some CID medications, can increase the risk of impaired fertility in addition to adverse maternal/pregnancy outcomes...
2.
A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan
Honma M, Suzuki N, Goto M, Obara T, Saito Y, Nakajima K, et al.
Congenit Anom (Kyoto) . 2024 Dec; 65(1):e12588. PMID: 39617399
We evaluated the teratogenic risk associated with exposure to cefditoren pivoxil during the first trimester of pregnancy using the integrated databases of the Toranomon Hospital and the National Center for...
3.
Effects of famotidine use during pregnancy: an observational cohort study
Nishimura A, Furugen A, Kobayashi M, Takekuma Y, Yakuwa N, Goto M, et al.
J Pharm Health Care Sci . 2024 Nov; 10(1):70. PMID: 39516928
Background: Famotidine, a histamine2-receptor antagonist (H2Ras), is widely used to treat and prevent gastrointestinal symptoms during pregnancy. Although several studies have reported the use of H2Ras during pregnancy, limited data...
4.
Assessment of the Safety of Exposure to Cefcapene Pivoxil during the First Trimester of Pregnancy: A Prospective Cohort Study in Japan
Miki Y, Koga Y, Taogoshi T, Itamura R, Yokooji T, Hishinuma K, et al.
Biol Pharm Bull . 2024 Jul; 47(7):1301-1306. PMID: 39010216
Cefcapene pivoxil hydrochloride is an antibiotic often used by women who are or may be pregnant. However, the safety of exposure to it during the first trimester of pregnancy has...
5.
Pregnancy outcomes after first-trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions
Goto M, Anzai T, Yamane R, Yakuwa N, Takahashi K, Murashima A
Congenit Anom (Kyoto) . 2024 Jun; 64(5):199-206. PMID: 38936845
Given the paucity of safety data on fluoroquinolone antibiotics in pregnancy, a prospective observational cohort study was conducted in pregnant women who sought help and advice on drug use at...
6.
Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy
Usuda M, Jwa S, Goto M, Kobayashi M, Nagano H, Yakuwa N, et al.
Congenit Anom (Kyoto) . 2024 Mar; 64(3):91-98. PMID: 38445786
To assess the risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol during pregnancy, we conducted a prospective cohort study using counseling data for drug use during...
7.
Pregnancy-related issues from the perspective of patients with inflammatory rheumatic diseases - Results from a survey of the members of the National Association for Inflammatory Rheumatic Diseases
Murashima A, Kaneko K, Oguro H, Mori Y, Goto M, Mishima S, et al.
Mod Rheumatol . 2024 Mar; 34(6):1162-1169. PMID: 38441892
Objectives: This study aimed to clarify the issues related to pregnancy in patients with inflammatory rheumatic diseases (RDs) and to provide useful information for developing medical services from patients' perspectives....
8.
Pregnancy Outcomes With Exposure to Second-Generation Antipsychotics During the First Trimester
Yakuwa N, Takahashi K, Anzai T, Ito N, Goto M, Koinuma S, et al.
J Clin Psychiatry . 2022 Jun; 83(4). PMID: 35687862
To investigate the risk of major congenital malformations associated with exposure to second-generation antipsychotics (SGAs) in the first trimester. Pregnant women who received consultation on drug exposure from the Japan...
9.
The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan
Hatakeyama S, Goto M, Yamamoto A, Ogura J, Watanabe N, Tsutsumi S, et al.
Congenit Anom (Kyoto) . 2022 May; 62(4):161-168. PMID: 35538631
For leukotriene receptor antagonists (LTRAs), especially pranlukast, safety data during pregnancy is limited. Therefore, we conducted a prospective, two-centered cohort study using data from teratogen information services in Japan to...
10.
Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases
Yonezawa H, Ikeda A, Takahashi R, Endo H, Sugawara Y, Goto M, et al.
iScience . 2022 May; 25(3):103912. PMID: 35530256
Ivermectin (IVM), an avermectin-derivative anthelmintic, specifically binds to glutamate-gated chloride ion channels (GluCls), causing paralysis in invertebrates. IVM also exhibits other biological activities such as Wnt/β-catenin pathway inhibition in vertebrates...